☆ 4.5 Article

Impact of short-term glycemic variability on risk of all-cause mortality in type 2 diabetes patients with well-controlled glucose profile by continuous glucose monitoring: A prospective cohort study

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Related references

Note: Only part of the references are listed.

Review Endocrinology & Metabolism

Glycaemic management in diabetes: old and new approaches

Antonio Ceriello et al.

Summary: The modern approach to glycemic control emphasizes not only achieving and maintaining optimal HbA(1c) concentrations, but also reducing postprandial hyperglycemia, glycemic variability, and extending time in near-normoglycemia. Hypoglycemia should be avoided, and if it occurs, should be reverted to normoglycemia. Utilizing modern technology and new drug therapies can help to shift the focus of glycemia management from HbA(1c) towards a more holistic approach considering all aspects of diabetes pathophysiology.

LANCET DIABETES & ENDOCRINOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes Mellitus

Anass El Malahi et al.

Summary: This study investigated the association between glycemic variability and time in range with chronic and acute diabetes complications. The results showed that lower time in range was associated with the presence of microvascular complications and hospitalization for hypoglycemia or ketoacidosis. However, glycemic variability was not associated with macrovascular complications.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Add to Collection

Article Endocrinology & Metabolism

Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study

Jingyi Lu et al.

Summary: The study found that lower TIR was associated with increased risk of all-cause and CVD mortality among patients with type 2 diabetes. This suggests the validity of TIR as a surrogate marker for long-term adverse clinical outcomes.

DIABETES CARE (2021)

Add to Collection

Review Endocrinology & Metabolism

Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the Gordian Knot''?

Louis Monnier et al.

Summary: Variability in glucose homeostasis plays a significant role in diabetes complications, especially in relation to hypoglycemic events. It is important to avoid excessive glucose fluctuations within a day and to understand that variability in glucose homeostasis is not only associated with cardiovascular events but also a causative factor for hypoglycemia.

DIABETES & METABOLISM (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Associations of hypoglycemia, glycemic variability and risk of cardiac arrhythmias in insulin-treated patients with type 2 diabetes: a prospective, observational study

Andreas Andersen et al.

Summary: This study found that cardiac arrhythmias were common in insulin-treated patients with type 2 diabetes, and were associated with glycemic variability rather than hypoglycemia.

CARDIOVASCULAR DIABETOLOGY (2021)

Add to Collection

Review Endocrinology & Metabolism

Glycemic variability and cardiovascular disease in patients with type 2 diabetes

Marcela Martinez et al.

Summary: Glycated hemoglobin is crucial for evaluating long-term glycemic control in diabetes patients, but it does not account for blood glucose fluctuations. Recent clinical data suggest that glycemic variability is associated with increased risks of complications in diabetes patients, independently of glycated hemoglobin levels.

BMJ OPEN DIABETES RESEARCH & CARE (2021)

Add to Collection

Review Endocrinology & Metabolism

Quality of Glycemic Control: Assessment Using Relationships Between Metrics for Safety and Efficacy

David Rodbard

Summary: This review suggests that only two metrics are sufficient for monitoring patients or comparing different forms of management interventions: one for efficacy evaluation and one for safety evaluation. By analyzing the relationships between safety and efficacy metrics, sensitivity can be improved and the need for arbitrary scoring systems can be avoided, offering the advantage of simplicity in both concept and practice.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Add to Collection

Article Endocrinology & Metabolism

Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes

Jingyi Lu et al.

Summary: The relationship between HbA1c and all-cause mortality among patients with type 2 diabetes varies depending on the degree of glycemic variability. In patients with high glycemic variability, HbA1c may not be a robust marker of mortality, suggesting the need for new metrics for better diabetes management in these individuals.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Add to Collection

Article Endocrinology & Metabolism

Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?

Louis Monnier et al.

DIABETES CARE (2020)

Add to Collection

Article Endocrinology & Metabolism

The Relationship Between CGM-Derived Metrics, A1C, and Risk of Hypoglycemia in Older Adults With Type 1 Diabetes

Elena Toschi et al.

DIABETES CARE (2020)

Add to Collection

Article Endocrinology & Metabolism

Impact of Glycemic Variability and Hypoglycemia on the Mortality and Length of Hospital Stay among Elderly Patients in Brazil

Danielle Bruginski et al.

CURRENT DIABETES REVIEWS (2020)

Add to Collection

Article Endocrinology & Metabolism

Association of glucose and blood pressure variability on oxidative stress in patients with type 2 diabetes mellitus and hypertension: a cross-sectional study

Makoto Ohara et al.

DIABETOLOGY & METABOLIC SYNDROME (2019)

Add to Collection

Article Endocrinology & Metabolism

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

Tadej Battelino et al.

DIABETES CARE (2019)

Add to Collection

Article Endocrinology & Metabolism

Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia

Ana Maria Gomez et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Add to Collection

Article Endocrinology & Metabolism

Continuous glucose monitoring defined glucose variability is associated with cardiovascular autonomic neuropathy in type 1 diabetes

Ji Eun Jun et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)

Add to Collection

Review Endocrinology & Metabolism

Technological Advancements in the Management of Type 2 Diabetes

Abigail Kennedy Grant et al.

CURRENT DIABETES REPORTS (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Glucose-sensing microRNA-21 disrupts ROS homeostasis and impairs antioxidant responses in cellular glucose variability

Lucia La Sala et al.

CARDIOVASCULAR DIABETOLOGY (2018)

Add to Collection

Article Endocrinology & Metabolism

DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality

Thomas R. Pieber et al.

DIABETOLOGIA (2018)

Add to Collection

Article Endocrinology & Metabolism

Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patients

Jee-Eun Yoon et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)

Add to Collection

Article Endocrinology & Metabolism

International Consensus on Use of Continuous Glucose Monitoring

Thomas Danne et al.

DIABETES CARE (2017)

Add to Collection

Article Endocrinology & Metabolism

Impact of Glycemic Variability on Chromatin Remodeling, Oxidative Stress, and Endothelial Dysfunction in Patients With Type 2 Diabetes and With Target HbA1c Levels

Sarah Costantino et al.

DIABETES (2017)

Add to Collection

Article Endocrinology & Metabolism

Glucose variability aggravates cardiac fibrosis by altering AKT signalling path

Changjiang Ying et al.

DIABETES & VASCULAR DISEASE RESEARCH (2017)

Add to Collection

Article Endocrinology & Metabolism

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial

John M. Lachin et al.

DIABETES CARE (2017)

Add to Collection

Article Endocrinology & Metabolism

Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability

Fabiana Picconi et al.

ACTA DIABETOLOGICA (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Glycemic Variability on Continuous Glucose Monitoring System Correlates With Non-Culprit Vessel Coronary Plaque Vulnerability in Patients With First-Episode Acute Coronary Syndrome

Masaomi Gohbara et al.

CIRCULATION JOURNAL (2015)

Add to Collection

Article Critical Care Medicine

Coefficient of glucose variation is independently associated with mortality in critically ill patients receiving intravenous insulin

Michael J. Lanspa et al.

CRITICAL CARE (2014)

Add to Collection

Article Endocrinology & Metabolism

Increased Glycemic Variability Is Independently Associated With Length of Stay and Mortality in Noncritically Ill Hospitalized Patients

Carlos E. Mendez et al.

DIABETES CARE (2013)

Add to Collection

Review Critical Care Medicine

Glucose variability measures and their effect on mortality: a systematic review

Saeid Eslami et al.

INTENSIVE CARE MEDICINE (2011)

Add to Collection

Article Endocrinology & Metabolism

Reference Values for Continuous Glucose Monitoring in Chinese Subjects

Jian Zhou et al.

DIABETES CARE (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.